Sanofi Sanofi (NASDAQ: SNY) Commence Phase II Study Of Its COVID-19 Vaccine Candidate Sanofi (NASDAQ: SNY) and GlaxoSmithKline Plc (NYSE: GSK) disclosed that they have commenced the Phase II study of their adjuvanted recombinant protein COVID-19 vaccine candidate.
